Barlinn 2016.
Study characteristics | |||
Patient Sampling | Retrospectively evaluated 346 consecutive patients with acute cerebral ischemia who were admitted to a tertiary stroke center. Patients were eligible if their diagnostic workup included DUS and CTA performed within 5 days of each other Exclusion criteria: quote "Patients who underwent acute revascularization therapy of the extracranial ICA prior to completion of both diagnostic studies were excluded from our analysis". |
||
Patient characteristics and setting | All patients were symptomatic, 346 patients with acute Ischemic stroke (n = 284) or transient ischemic attack (n = 62) 303 acute cerebral Ischemic patients included in analyses Mean age, 72 ± 12 years. 58% men and 42% women; median baseline National Institutes of Health Stroke Scale score, 4 [IQR 7] No information on risk factor |
||
Index tests |
DUS . Image production: Duplex ultrasonography (Toshiba Aplio MX SSA‐780a System®, Toshiba Medical Systems, Germany) with a 7.5–10‐MHz linear array transducer was used for examinations of the extracranial carotid arteries. Contrast: No Criteria used to determine grade of stenosis: DEGUM ultrasound criteria (Appendix 9Arning 2010) |
||
Target condition and reference standard(s) |
Reference standard: CTA Target condition: assessment of extracranial ICA steno‐occlusive disease in patients with acute cerebral ischemia Criteria used to determine grade of stenosis: NASCET criteria Complications: Not described |
||
Flow and timing | 43 patients (12%) were not eligible for the final analysis due to the following reasons: ultrasonographic assessment after acute revascularization therapy, n = 13; elapsed time between DUS and CTA > 5 days, n = 23; and only one vascular imaging modality assessable (e.g. streak artefacts from dental implants on CTA), n = 7. The median elapsed time between DUS and CTA was 1 (IQR, 2) day |
||
Comparative | |||
Methods |
Study design: Retrospective design; participants identified retrospectively based on availability of complete records, if their diagnostic workup included DUS and CTA performed within 5 days Study location: Germany Year and language of publication: Published in 2016 in English Study period: from January 2012 to December 2012 Participants enrolled: 303 patients Carotids included in analyses: 593 DUS and CTA carotid artery pairs available for comparison |
||
Notes | Only included retrospectively patients that had undergone the index and the reference tests; unclear if DUS results were used to select patients to CTA | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Could the selection of patients have introduced bias? | Unclear risk | ||
Are there concerns that the included patients and setting do not match the review question? | Low concern | ||
DOMAIN 2: Index Test (All tests) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Could the conduct or interpretation of the index test have introduced bias? | Low risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | Low risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | No | ||
Could the patient flow have introduced bias? | High risk |